Applied Dna Sciences Inc financial data

Symbol
APDN on Nasdaq
Industry
Services-Testing Laboratories
Location
50 Health Sciences Drive, Stony Brook, NY
State of incorporation
DE
Fiscal year end
September 30
Former names
PROHEALTH MEDICAL TECHNOLOGIES INC (to 12/18/2002), DCC ACQUISITION CORP (to 5/4/2001), DATALINK CAPITAL CORP/TX/ (to 2/8/1999)
Latest financial report
10-K - Q3 2024 - Dec 17, 2024

Key Ratios

Label TTM Value / Value Unit Change %
Current Ratio 271 % -36.2%
Quick Ratio 15.3 % +33.9%
Debt-to-equity 91 % -24.3%
Return On Equity -111 % +12.8%
Return On Assets -57.6 % +0.26%

Shares

Label TTM Value / Value Unit Change %
Entity Common Stock, Shares Outstanding 52.3M shares +280%
Common Stock, Shares, Outstanding 10.3M shares +1410%
Entity Public Float 5.7M USD -60.4%
Common Stock, Value, Issued 10.3K USD +1410%
Weighted Average Number of Shares Outstanding, Basic 3.97M shares +507%
Weighted Average Number of Shares Outstanding, Diluted 3.97M shares +507%

Income Statement

Label TTM Value / Value Unit Change %
Cost of Revenue 2.41M USD -69.2%
Research and Development Expense 3.59M USD -3.78%
Operating Income (Loss) -14M USD -28%
Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest -7.09M USD +29.3%
Income Tax Expense (Benefit) 0 USD
Net Income (Loss) Attributable to Parent -6.99M USD +29.7%
Earnings Per Share, Basic -1.82 USD/shares +88%
Earnings Per Share, Diluted -1.82 USD/shares +88%

Balance Sheet

Label TTM Value / Value Unit Change %
Cash and Cash Equivalents, at Carrying Value 10.1M USD +201%
Accounts Receivable, after Allowance for Credit Loss, Current 362K USD +41.7%
Inventory, Net 439K USD +32.9%
Assets, Current 8.05M USD -0.97%
Property, Plant and Equipment, Net 553K USD -34%
Operating Lease, Right-of-Use Asset 739K USD -40.3%
Intangible Assets, Net (Excluding Goodwill) 2.7M USD 0%
Assets 12.8M USD -6.32%
Accounts Payable, Current 1.17M USD +8.73%
Contract with Customer, Liability, Current 58.8K USD -23.1%
Liabilities, Current 2.4M USD -15.7%
Contract with Customer, Liability, Noncurrent 194K USD 0%
Deferred Income Tax Liabilities, Net 684K USD 0%
Operating Lease, Liability, Noncurrent 193K USD -73.9%
Liabilities 3.82M USD -56.5%
Retained Earnings (Accumulated Deficit) -310M USD -2.39%
Stockholders' Equity Attributable to Parent 9.14M USD +84.7%
Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest 8.97M USD +84.1%
Liabilities and Equity 12.8M USD -6.32%

Popular Metrics

Label TTM Value / Value Unit Change %
Net Cash Provided by (Used in) Operating Activities -3.76M USD -57.7%
Net Cash Provided by (Used in) Financing Activities -35.1K USD
Net Cash Provided by (Used in) Investing Activities 45K USD
Common Stock, Shares Authorized 200M shares 0%
Common Stock, Shares, Issued 10.3M shares +1410%
Common Stock, Par or Stated Value Per Share 0 USD/shares 0%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect -3.79M USD -62.2%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents 7.18M USD -9.12%
Interest Paid, Excluding Capitalized Interest, Operating Activities 0 USD
Deferred Tax Assets, Valuation Allowance 24.7M USD -20.2%
Deferred Tax Assets, Gross 24.9M USD -20.5%
Operating Lease, Liability 739K USD -40.3%
Payments to Acquire Property, Plant, and Equipment 0 USD -100%
Lessee, Operating Lease, Liability, to be Paid 782K USD -42.9%
Property, Plant and Equipment, Gross 4.66M USD +9.69%
Operating Lease, Liability, Current 546K USD +9.49%
Lessee, Operating Lease, Liability, to be Paid, Year Two 195K USD -66.7%
Lessee, Operating Lease, Liability, to be Paid, Year One 586K USD 0%
Operating Lease, Weighted Average Discount Rate, Percent 0.09 pure 0%
Lessee, Operating Lease, Liability, Undiscounted Excess Amount 42.6K USD -67.3%
Lessee, Operating Lease, Liability, to be Paid, Year Three 195K USD
Deferred Tax Assets, Operating Loss Carryforwards 18.5M USD -26.9%
Preferred Stock, Shares Issued 0 shares
Preferred Stock, Shares Authorized 10M shares 0%
Preferred Stock, Shares Outstanding 0 shares
Depreciation, Depletion and Amortization 299K USD -11.8%
Deferred Tax Assets, Net of Valuation Allowance 0 USD
Preferred Stock, Par or Stated Value Per Share 0 USD/shares 0%